An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of CNTO 136 administered
intravenously in patients with active, International Society of Nephrology/Renal Pathology
Society Class III and IV Lupus Nephritis (LN).